Investment accounts
Adult accounts
Child accounts
Choosing Fidelity
Choosing Fidelity
Why invest with us Current offers Fees and charges Open an account Transfer investments
Financial advice & support
Fidelity’s Services
Fidelity’s Services
Financial advice Retirement Wealth Management Investor Centre (London) Bereavement
Guidance and tools
Guidance and tools
Choosing investments Choosing accounts ISA calculator Retirement calculators
Share dealing
Choose your shares
Tools and information
Tools and information
Share prices and markets Chart and compare shares Stock market news Shareholder perks
Pensions & retirement
Pensions, tax & tools
Saving for retirement
Approaching / In retirement
Approaching / In retirement
Speak to a specialist Creating a retirement plan Taking tax-free cash Pension drawdown Annuities Investing in retirement Investment Pathways
FTSE 100 movers: Smith & Nephew surges on Cevian stake; Next goes ex-div
(Sharecast News) - London's FTSE 100 was up 0.7% at 8,231.30 in afternoon trade on Thursday.
Smith & Nephew shot higher after activist investor Cevian Capital bought a 5% stake in the medical equipment manufacturer. Cevian now holds 43.9m shares in the company, making it the third largest shareholder.
Russ Mould, investment director at AJ Bell, said: "Cevian has previously taken positions in UBS, Vodafone and Aviva in an attempt to force change and the case for doing so at Smith & Nephew is presented by a near-40% decline in the share price over the last five years.
"The positive share price reaction to Cevian taking a position in Smith & Nephew demonstrates the market thinks an outside catalyst for a shake-up of the business would be no bad thing.
"The company was severely affected by the pandemic as elective procedures like hip and knee replacements were cancelled, reducing demand for its orthopaedic products. Lockdown also hit the company's supply chain, as it did for many businesses.
"However, its post-Covid recovery has been faltering and an improvement plan announced in 2022 has not yet resulted in a material improvement in earnings and profitability. This hasn't been helped by a weak showing in the US market.
"Cevian is likely to hold management's feet to the fire and may look for more ambitious targets than set out under the existing improvement plan. It could also push for a rationalisation of the company's portfolio, which encompasses sports medicine and wound care alongside orthopaedics."
Distribution and outsourcing firm Bunzl was boosted by an upgrade to 'buy' at HSBC.
Barclays rose after saying it had agreed to sell its German consumer finance business to Austrian bank Bawag Group for "a small premium" to net assets.
Next was in the red as it traded without entitlement to the dividend.
FTSE 100 - Risers
Smith & Nephew (SN.) 1,059.50p 7.43% Melrose Industries (MRO) 575.40p 2.97% Bunzl (BNZL) 3,120.00p 2.90% Barclays (BARC) 224.20p 2.77% Vistry Group (VTY) 1,259.00p 2.44% Standard Chartered (STAN) 738.20p 2.16% Lloyds Banking Group (LLOY) 56.92p 1.86% WPP (WPP) 742.80p 1.73% Rolls-Royce Holdings (RR.) 463.50p 1.69% IMI (IMI) 1,810.00p 1.69%
FTSE 100 - Fallers
Next (NXT) 8,976.00p -1.49% Spirax Group (SPX) 8,520.00p -0.76% Darktrace (DARK) 579.60p -0.69% easyJet (EZJ) 460.50p -0.52% Halma (HLMA) 2,708.00p -0.33% Haleon (HLN) 325.40p -0.21% Land Securities Group (LAND) 636.00p -0.16% Rightmove (RMV) 537.80p -0.15% Croda International (CRDA) 4,084.00p -0.15% Auto Trader Group (AUTO) 802.40p 0.00%
Share this article
Related Sharecast Articles
Important information: This information is not a personal recommendation for any particular investment. If you are unsure about the suitability of an investment you should speak to one of Fidelity’s advisers or an authorised financial adviser of your choice. When you are thinking about investing in shares, it’s generally a good idea to consider holding them alongside other investments in a diversified portfolio of assets. Past performance is not a reliable indicator of future returns.
Award-winning online share dealing
Search, compare and select from thousands of shares.
Expert insights into investing your money
Our team of experts explore the world of share dealing.
Policies and important information
Accessibility | Conflicts of interest statement | Consumer Duty Target Market | Consumer Duty Value Assessment Statement | Cookie policy | Diversity and Inclusion | Doing Business with Fidelity | Fidelity gender pay report | Investing in Fidelity funds | Legal information | Modern slavery | Mutual respect policy | Privacy statement | Remuneration policy | Security | Statutory and Regulatory disclosures | Whistleblowing policy
Please remember that past performance is not necessarily a guide to future performance, the performance of investments is not guaranteed, and the value of your investments can go down as well as up, so you may get back less than you invest. When investments have particular tax features, these will depend on your personal circumstances and tax rules may change in the future. This website does not contain any personal recommendations for a particular course of action, service or product. You should regularly review your investment objectives and choices and, if you are unsure whether an investment is suitable for you, you should contact an authorised financial adviser. Before opening an account, please read the ‘Doing Business with Fidelity’ document which incorporates our client terms. Prior to investing into a fund, please read the relevant key information document which contains important information about the fund.
This website is issued by Financial Administration Services Limited, which is authorised and regulated by the Financial Conduct Authority (FCA) (FCA Register number 122169) and registered in England and Wales under company number 1629709 whose registered address is Beech Gate, Millfield Lane, Lower Kingswood, Tadworth, Surrey, KT20 6RP.
